1301256-39-2

Basic information

• Product Name: 2-(4-(N-methyl-N-tert-butoxycarbonylamino)phenyl)benzo[d]thiazol-6-ol
• Synonyms: 2-(4-(N-methyl-N-tert-butoxycarbonylamino)phenyl)benzo[d]thiazol-6-ol
• CAS NO: 1301256-39-2
• Molecular Weight: 356.445
• Mol File: 1301256-39-2.mol

Chemical Properties

• CAS DataBase Reference: 2-(4-(N-methyl-N-tert-butoxycarbonylamino)phenyl)benzo[d]thiazol-6-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-(N-methyl-N-tert-butoxycarbonylamino)phenyl)benzo[d]thiazol-6-ol(1301256-39-2)
• EPA Substance Registry System: 2-(4-(N-methyl-N-tert-butoxycarbonylamino)phenyl)benzo[d]thiazol-6-ol(1301256-39-2)

Safety Data

• Hazardous Substances Data: 1301256-39-2(Hazardous Substances Data)

Upstream product

• 566169-93-5 2-(4-(methylamino)phenyl)benzo[d]thiazol-6-ol 
• 178804-18-7 2-(4’-aminophenyl)-6-hydroxybenzothiazole 
• 480391-86-4 6-hydroxy-2-(4'-nitrophenyl)-1,3-benzothiazole 
• 73702-95-1 N-(4-methoxyphenyl)-4-nitrothiobenzamide 
• 401813-34-1 4-(6-methoxybenzo[d]thiazol-2-yl)-N-methylaniline 
• 43036-17-5 2-(4-aminophenyl)-6-methoxybenzothiazole 
• 24424-99-5 di-tert-butyl dicarbonate 
• 122-04-3 4-nitro-benzoyl chloride 
• 104-94-9 4-methoxy-aniline 
• 24730-11-8 N-(4-methoxyphenyl)-4-nitrobenzamide 

Relevant articles and documents

COMPOUND FOR BORON NEUTRON CAPTURE THERAPY FOR AMYLOID β DISEASES

PROBLEM TO BE SOLVED: To provide a boron carrier compound having high binding specificity to an amyloid β protein, high permeability through the blood brain barrier, and a retention property in senile plaques in the brain, while having a property less lik

For nerve degenerative disease is in the field of PET imaging agent precursor and the standard method for the synthesis of (by machine translation)

A novel PET imaging agent precursor and standard and its preparation method, in order to 4-nitro cinnamic aldehyde, the methoxylphenylboronic ethylamine as a reaction initiator, synthesis of the precursor (compound 10) 4 - (6 - (2-P-toluene-sulfonic acid ethoxycarbonyl)-oxy-2-quinolyl)-N-tert-butoxy-carbonyl-N-n-pentyl-( [N-methyl-N-tert-butoxy carbonyl] - 2 - [4 ˊ - (methylamino) phenyl]-benzothiazole aniline) - 6-ether) aniline and standard (compound 25) 4 - (6 - (2-F)-oxy-2-quinolyl)-N-n-pentyl-( [N-methyl] - 2 - [4 ˊ - (methylamino) phenyl]-benzothiazole aniline) - 6-ether) aniline, at the same time provides A β protein specific binding agent 11 C-6-OH-BTA-1 an important intermediate for preparing (compound 7) method for the preparation of, the preparation method is a brand new synthetic route, step is simple, moderate reaction. (by machine translation)

(3-FLUORO-2-HYDROXY)PROPYL-FUNCTIONALIZED ARYL DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR THE DIAGNOSIS OR TREATMENT OF NEURODEGENERATIVE BRA

The present invention relates to (3-fluoro-2-hydroxy)propyl-functionalized aryl derivatives or to the pharmaceutically acceptable salt thereof, to a method for preparing same, and to a pharmaceutical composition containing same as active ingredients for t